GAPDH oxidation and aggregation has been reported in a number of diseases in which macrophages and myeloperoxidase (MPO)-derived reactive species have been observed, including Alzheimer’s, Lou Gehrig’s, Huntington’s, and Parkinson’s diseases [2]. This evidence concerns the gene MPO and Parkinson disease.